EPHB2 Gene Variants in Colorectal Cancer Patients
Author Information
Author(s): Antti Kokko, Päivi Laiho, Rainer Lehtonen, Sanna Korja, Luis G Carvajal-Carmona, Heikki Järvinen, Jukka-Pekka Mecklin, Charis Eng, Johanna Schleutker, Ian PM Tomlinson, Pia Vahteristo, Lauri A Aaltonen
Primary Institution: University of Helsinki
Hypothesis
EPHB2 germline alterations may predispose to colorectal tumors.
Conclusion
The study found novel EPHB2 alterations in colorectal cancer patients, suggesting a limited role for these variants in tumor predisposition.
Supporting Evidence
- Four previously unknown missense alterations in the EPHB2 gene were identified.
- The alterations were not found in a large number of healthy controls.
- The study suggests that EPHB2 variants may have a limited role in colorectal cancer predisposition.
Takeaway
Scientists looked at a gene called EPHB2 in people with colorectal cancer and found some changes that might be linked to the disease, but they think these changes don't play a big role in causing cancer.
Methodology
The EPHB2 gene was analyzed for germline alterations in 101 individuals with colorectal cancer or hyperplastic polyposis using direct sequencing.
Limitations
The rarity of EPHB2 alterations suggests they may not significantly contribute to colorectal cancer risk.
Participant Demographics
Participants included 63 with colorectal cancer and 38 with hyperplastic polyposis, with ages ranging from 16 to 85 years.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website